Funded Tech Companies

Ruxton Pharmaceuticals

Wondering who provided funding to Ruxton Pharmaceuticals? New Enterprise Associates and Domain Associates joined the equity holders in this biopharmaceutical company.

Company Overview

Company Name
Ruxton Pharmaceuticals
Company Status
Out of Business
Funding Rounds

Contact Information

Mailing Address
2330 W. Joppa Road 355
Lutherville, MD 21093
USA
Email Address

Company Background Information

Overview
Ruxton Pharmaceuticals is an emerging pharmaceutical company that has been formed to discover, develop and market drugs for the treatment of neurodegenerative diseases.
Profile
Ruxton Pharmaceuticals LinkedIn Company Profile
Social Media
Ruxton Pharmaceuticals Company Twitter Account
Company News
Ruxton Pharmaceuticals News
Facebook
Ruxton Pharmaceuticals on Facebook
YouTube
Ruxton Pharmaceuticals on YouTube
Last Transaction
11/10/2008

Financing History

Date
Type
Amount
Venture Equity
$8,000,000
Venture Equity
$3,570,000
Venture Equity
$1,700,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Richard Chipkin
  Richard Chipkin LinkedIn Profile  Richard Chipkin Twitter Account  Richard Chipkin News  Richard Chipkin on Facebook
Chief Scientific Officer
Rita Sattler
  Rita Sattler LinkedIn Profile  Rita Sattler Twitter Account  Rita Sattler News  Rita Sattler on Facebook
Founder
Jeffrey Rothstein
  Jeffrey Rothstein LinkedIn Profile  Jeffrey Rothstein Twitter Account  Jeffrey Rothstein News  Jeffrey Rothstein on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

Ruvna | RVAC Medicines

 

Share this article

 


About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary